BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36612170)

  • 1. The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer.
    Lisanti C; Basile D; Garattini SK; Parnofiello A; Corvaja C; Cortiula F; Bertoli E; Ongaro E; Foltran L; Casagrande M; Di Nardo P; Cardellino GG; Fasola G; Buonadonna A; Pella N; Aprile G; Puglisi F
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SENECA study: Prognostic role of serum biomarkers in older patients with metastatic colorectal cancer.
    Lisanti C; Basile D; Parnofiello A; Bertoli E; Andreotti VJ; Garattini SK; Bartoletti M; Cattaneo M; Di Nardo P; Bonotto M; Casagrande M; Da Ros L; Cinausero M; Foltran L; Pella N; Buonadonna A; Aprile G; Fasola G; Puglisi F
    J Geriatr Oncol; 2020 Nov; 11(8):1268-1273. PubMed ID: 32576519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MIMIC Study: Prognostic Role and Cutoff Definition of Monocyte-to-Lymphocyte Ratio and Lactate Dehydrogenase Levels in Metastatic Colorectal Cancer.
    Basile D; Garattini SK; Corvaja C; Montico M; Cortiula F; Pelizzari G; Gerratana L; Audisio M; Lisanti C; Fanotto V; Ongaro E; Iacono D; Cardellino GG; Foltran L; Pella N; Buonadonna A; Aprile G; Di Maio M; Fasola G; Puglisi F
    Oncologist; 2020 Aug; 25(8):661-668. PubMed ID: 32202020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer].
    Huang L; Fang J; Wu J; Zhou X; Wei H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1421-1426. PubMed ID: 30588596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Value of Neutrophil-to-lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Metastatic Gastric Cancer Treated with Systemic Chemotherapy.
    Zhou D; Wu Y; Zhu Y; Lin Z; Yu D; Zhang T
    J Cancer; 2020; 11(14):4205-4212. PubMed ID: 32368303
    [No Abstract]   [Full Text] [Related]  

  • 6. The Prognostic Value of Inflammation Factors in Hepatocellular Carcinoma Patients with Hepatic Artery Interventional Treatments: A Retrospective Study.
    Guo L; Ren H; Pu L; Zhu X; Liu Y; Ma X
    Cancer Manag Res; 2020; 12():7173-7188. PubMed ID: 33061563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.
    Cong R; Kong F; Ma J; Li Q; Wu Q; Ma X
    BMC Cancer; 2020 May; 20(1):464. PubMed ID: 32448185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
    Huemer F; Thaler J; Piringer G; Hackl H; Pleyer L; Hufnagl C; Weiss L; Greil R
    BMC Cancer; 2018 Jan; 18(1):11. PubMed ID: 29298682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma.
    Zhu Z; Xu L; Zhuang L; Ning Z; Zhang C; Yan X; Lin J; Shen Y; Wang P; Meng Z
    Onco Targets Ther; 2018; 11():6731-6740. PubMed ID: 30349306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative neutrophil-to-lymphocyte, platelet-to-lymphocyte and monocyte-to-lymphocyte ratio as a prognostic factor in non-endometrioid endometrial cancer.
    Song H; Jeong MJ; Cha J; Lee JS; Yoo JG; Song MJ; Kim JH; Lee SJ; Lee HN; Yoon JH; Park DC; Kim SI
    Int J Med Sci; 2021; 18(16):3712-3717. PubMed ID: 34790044
    [No Abstract]   [Full Text] [Related]  

  • 11. Prognostic value of skeletal muscle index and monocyte-to-lymphocyte ratio for lymph node-positive breast cancer patients after mastectomy.
    Deng JP; Hua X; Long ZQ; Zhang WW; Lin HX; He ZY
    Ann Transl Med; 2019 Dec; 7(23):775. PubMed ID: 32042791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis.
    Kamran SC; Clark JW; Zheng H; Borger DR; Blaszkowsky LS; Allen JN; Kwak EL; Wo JY; Parikh AR; Nipp RD; Murphy JE; Goyal L; Zhu AX; Iafrate AJ; Corcoran RB; Ryan DP; Hong TS
    Cancer Med; 2018 Jul; 7(7):2934-2942. PubMed ID: 29771009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study.
    Fan Z; Li Y; Ji H; Jian X
    BMJ Open; 2018 Oct; 8(10):e023459. PubMed ID: 30341133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO.
    Dell'Aquila E; Cremolini C; Zeppola T; Lonardi S; Bergamo F; Masi G; Stellato M; Marmorino F; Schirripa M; Urbano F; Ronzoni M; Tomasello G; Zaniboni A; Racca P; Buonadonna A; Allegrini G; Fea E; Di Donato S; Chiara S; Tonini G; Tomcikova D; Boni L; Falcone A; Santini D
    Ann Oncol; 2018 Apr; 29(4):924-930. PubMed ID: 29324972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
    Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
    Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte to lymphocyte ratio predicts survival in patients with advanced gastric cancer undergoing neoadjuvant chemotherapy.
    Chen L; Hao Y; Zhu L; Li S; Zuo Y; Zhang Y; Song H; Xue Y
    Onco Targets Ther; 2017; 10():4007-4016. PubMed ID: 28860808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy.
    Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Elevated Peripheral Blood Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Primary Pulmonary Lymphoepithelioma-Like Carcinoma.
    Wang L; Long W; Li PF; Lin YB; Liang Y
    PLoS One; 2015; 10(5):e0126269. PubMed ID: 25950432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic utility of the combination of pretreatment monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NMIBC after transurethral resection.
    Wang Q; Huang T; Ji J; Wang H; Guo C; Sun X; Zheng K; Dong Z; Cao Y
    Biomark Med; 2019 Dec; 13(18):1543-1555. PubMed ID: 31621380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer].
    Zhou WJ; Wu J; Li XD; Wang Q; Ni XF; Jiang JT; Ji M; Wu CP
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):178-183. PubMed ID: 28316215
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.